Hochschulschrift
Alzheimer's disease - pathomechanisms and novel therapeutic strategies
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Maße
-
30 cm
- Umfang
-
48 Seiten, 48 verschieden gezählte Seiten
- Sprache
-
Englisch
- Anmerkungen
-
Illustrationen, Diagramme
Enthält Sonderabdrucke
Technische Universität München, Habilitationsschrift, 2016
- Ereignis
-
Veröffentlichung
- (wo)
-
München
- (wann)
-
2017
- Urheber
-
Busche, Marc Aurel
- Inhaltsverzeichnis
- Rechteinformation
-
Bei diesem Objekt liegt nur das Inhaltsverzeichnis digital vor. Der Zugriff darauf ist unbeschränkt möglich.
- Letzte Aktualisierung
-
11.03.2025, 12:28 MEZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Objekttyp
- Hochschulschrift
Beteiligte
- Busche, Marc Aurel
Entstanden
- 2017
Ähnliche Objekte (12)
Alzheimer disease : therapeutic strategies
Initial Aβ seeds as therapeutic target for Alzheimer’s disease
Building multiscale computable model of Alzheimer’s disease and identification of novel mechanisms for new therapeutic interventions
Progressive neuroblastoma : innovation and novel therapeutic strategies
Measuring therapeutic efficacy in patients with Alzheimer’s disease: role of instruments
From pathological mechanisms underlying cardiovascular disease to novel therapeutic strategies in high-risk patients
Developing new models, unveiling disease mechanisms and identifying novel therapeutic strategies for cardiovascular diseases
Alzheimer’s disease: Amyloid oligomers, therapeutic agents, their target and mode of action
Renal cell carcinoma in von Hippel-Lindau disease - from tumor genetics to novel therapeutic strategies
Alzheimer's disease
Promising Novel Therapeutic Strategies for Cisplatin Resistant Bladder Cancer
Sleep as a Novel Biomarker and a Promising Therapeutic Target for Cerebral Small Vessel Disease: A Review Focusing on Alzheimer’s Disease and the Blood-Brain Barrier
Alzheimer disease : therapeutic strategies
Initial Aβ seeds as therapeutic target for Alzheimer’s disease
Building multiscale computable model of Alzheimer’s disease and identification of novel mechanisms for new therapeutic interventions
Progressive neuroblastoma : innovation and novel therapeutic strategies
Measuring therapeutic efficacy in patients with Alzheimer’s disease: role of instruments
From pathological mechanisms underlying cardiovascular disease to novel therapeutic strategies in high-risk patients
Developing new models, unveiling disease mechanisms and identifying novel therapeutic strategies for cardiovascular diseases
Alzheimer’s disease: Amyloid oligomers, therapeutic agents, their target and mode of action
Renal cell carcinoma in von Hippel-Lindau disease - from tumor genetics to novel therapeutic strategies
Alzheimer's disease
Promising Novel Therapeutic Strategies for Cisplatin Resistant Bladder Cancer
Sleep as a Novel Biomarker and a Promising Therapeutic Target for Cerebral Small Vessel Disease: A Review Focusing on Alzheimer’s Disease and the Blood-Brain Barrier
Alzheimer disease : therapeutic strategies
Initial Aβ seeds as therapeutic target for Alzheimer’s disease
Building multiscale computable model of Alzheimer’s disease and identification of novel mechanisms for new therapeutic interventions
Progressive neuroblastoma : innovation and novel therapeutic strategies
Measuring therapeutic efficacy in patients with Alzheimer’s disease: role of instruments
From pathological mechanisms underlying cardiovascular disease to novel therapeutic strategies in high-risk patients
Developing new models, unveiling disease mechanisms and identifying novel therapeutic strategies for cardiovascular diseases
Alzheimer’s disease: Amyloid oligomers, therapeutic agents, their target and mode of action
Renal cell carcinoma in von Hippel-Lindau disease - from tumor genetics to novel therapeutic strategies
Alzheimer's disease
Promising Novel Therapeutic Strategies for Cisplatin Resistant Bladder Cancer